This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Baker Heart and Diabetes Institute, Zora Biosciences Oy. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: The Innovative Contributions of Jonathan Shaw
Introduction
Jonathan Shaw is a notable inventor based in North Caulfield, Australia. He has made significant strides in the field of medical diagnostics, particularly in the early detection of diabetes and related conditions. His work has the potential to impact the lives of many individuals at risk of developing serious health issues.
Latest Patents
Jonathan Shaw holds a patent for "Methods for prediction and early detection of diabetes." This innovative patent describes an in vitro method for assessing whether a subject is at risk of developing or is suffering from fatty liver disease. The method involves assaying a sample from the subject to determine the concentration of fatty liver biomarkers from specific groups. The results can indicate if the subject is at an increased risk of developing fatty liver disease based on the biomarker values compared to a control.
Career Highlights
Throughout his career, Jonathan has worked with reputable organizations, including Zora Biosciences Oy and the Baker Heart and Diabetes Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jonathan has collaborated with notable colleagues such as Kevin Huynh and Dianna Magliano. These partnerships have fostered an environment of innovation and have led to advancements in understanding diabetes and its related conditions.
Conclusion
Jonathan Shaw's contributions to medical diagnostics through his innovative patent and collaborations highlight his commitment to improving health outcomes. His work continues to pave the way for advancements in the early detection of diabetes and fatty liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile